Holiday Notification: Cayman Chemical will be closed Monday, May 28, 2012, in observance of the Memorial Day holiday.
More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, May 29, 2012. Thank you for your patience and understanding.
The tetracycline repressor (TetR) is a transcriptional regulator which normally binds tightly to its palindromic tetO operator DNA, blocking gene expression.1 Tet causes the repressor to dissociate from the DNA, allowing transcription to occur. A novel reverse TetR (revTetR) requires tetracycline as a co-repressor to bind tetO and block transcription.2,3 Anhydrotetracycline (hydrochloride) is a powerful effector in both the TetR and revTetR systems, binding the TetR 35-fold more strongly than Tet.4,1 Moreover, anhydrotetracycline poorly binds the 30S ribosomal subunit, compared to Tet,5 so it does not act as a general inhibitor of translation and is a poor antibiotic. Perhaps related to this, the concentration of anhydrotetracycline that inhibits eukaryotic cell growth is more than a 1,000-fold above the dose that alters transcription through TetR.1
1
Gossen, M., and Bujard, H. Anhydrotetracycline, a novel effector for tetracycline controlled gene expression systems in eukaryotic cells. Nucleic Acids Res21(18)4411-4412(1993).
2
Kamionka, A., Bogdanska-Urbaniak, J., Scholz, O., et al. Two mutations in the tetracycline repressor change the inducer anhydrotetracycline to a corepressor. Nucleic Acids Res32(2)842-847(2004).
3
Resch, M., Striegl, H., Henssler, E.M., et al. A protein functional leap: How a single mutation reverses the function of the transcription regulator TetR. Nucleic Acids Res36(13)4390-4401(2008).
4
Degenkolb, J., Takahashi, M., Ellestad, G.A., et al. Structural requirements of tetracycline-Tet repressor interaction: Determination of equilibrium binding constants for tetracycline analogs with the Tet repressor. Antimicrob Agents Chemother35(8)1591-1595(1991).
5
Rasmussen, B., Noller, H.F., Daubresse, G., et al. Molecular basis of tetracycline action: Identification of analogs whose primary target is not the bacterial ribosome. Antimicrob Agents Chemother35(11)2306-2311(1991).
Gossen, M., and Bujard, H. Anhydrotetracycline, a novel effector for tetracycline controlled gene expression systems in eukaryotic cells. Nucleic Acids Res21(18)4411-4412(1993).
Resch, M., Striegl, H., Henssler, E.M., et al. A protein functional leap: How a single mutation reverses the function of the transcription regulator TetR. Nucleic Acids Res36(13)4390-4401(2008).
Degenkolb, J., Takahashi, M., Ellestad, G.A., et al. Structural requirements of tetracycline-Tet repressor interaction: Determination of equilibrium binding constants for tetracycline analogs with the Tet repressor. Antimicrob Agents Chemother35(8)1591-1595(1991).
Rasmussen, B., Noller, H.F., Daubresse, G., et al. Molecular basis of tetracycline action: Identification of analogs whose primary target is not the bacterial ribosome. Antimicrob Agents Chemother35(11)2306-2311(1991).
Kamionka, A., Bogdanska-Urbaniak, J., Scholz, O., et al. Two mutations in the tetracycline repressor change the inducer anhydrotetracycline to a corepressor. Nucleic Acids Res32(2)842-847(2004).